It is an immunomodulating drug, mostly used for treating multiple sclerosis (ms). it has reduced the rate of relapses in relapsing-remitting multiple sclerosis by approximately one-half over a two-year period. fingolimod is a sphingosine-1-phosphate receptor modulator, which sequesters lymphocytes in lymph nodes, preventing them from contributing to an autoimmune reaction.